Your browser doesn't support javascript.
loading
Personalized risk for clinical progression in cognitively normal subjects-the ABIDE project.
van Maurik, Ingrid S; Slot, Rosalinde E R; Verfaillie, Sander C J; Zwan, Marissa D; Bouwman, Femke H; Prins, Niels D; Teunissen, Charlotte E; Scheltens, Philip; Barkhof, Frederik; Wattjes, Mike P; Molinuevo, Jose Luis; Rami, Lorena; Wolfsgruber, Steffen; Peters, Oliver; Jessen, Frank; Berkhof, Johannes; van der Flier, Wiesje M.
Afiliação
  • van Maurik IS; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. i.vanmaurik@vumc.nl.
  • Slot RER; Department of Epidemiology and Biostatistics, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. i.vanmaurik@vumc.nl.
  • Verfaillie SCJ; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Zwan MD; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Bouwman FH; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Prins ND; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Teunissen CE; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Scheltens P; Brain Research Center, Amsterdam, The Netherlands.
  • Barkhof F; Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Wattjes MP; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Molinuevo JL; Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Rami L; Institutes of Neurology and Healthcare Engineering, UCL, London, UK.
  • Wolfsgruber S; Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Peters O; Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic, Barcelona, Spain and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Jessen F; Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic, Barcelona, Spain and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Berkhof J; Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany.
  • van der Flier WM; German Center for Neurodegenerative Diseases, Bonn, Germany.
Alzheimers Res Ther ; 11(1): 33, 2019 04 16.
Article em En | MEDLINE | ID: mdl-30987684
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Progressão da Doença / Disfunção Cognitiva Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Progressão da Doença / Disfunção Cognitiva Idioma: En Ano de publicação: 2019 Tipo de documento: Article